https://orcid.org/0000-0002-9612-1055
About the Authors
- Michael H. Peters
-
Contributed equally to this work with: Michael H. Peters, Oscar Bastidas, Daniel S. Kokron, Christopher E. Henze
Roles Conceptualization, Formal analysis, Methodology, Software, Writing – original draft
* E-mail: mpeters@vcu.edu
Affiliation Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Oscar Bastidas
-
Contributed equally to this work with: Michael H. Peters, Oscar Bastidas, Daniel S. Kokron, Christopher E. Henze
Roles Formal analysis, Methodology, Software, Writing – review & editing
Affiliation College of Biological Sciences, University of Minnesota, Minneapolis, Minnesota, United States of America
- Daniel S. Kokron
-
Contributed equally to this work with: Michael H. Peters, Oscar Bastidas, Daniel S. Kokron, Christopher E. Henze
Roles Formal analysis, Methodology, Software, Writing – review & editing
Affiliation NASA Ames Research Center, Moffett Field, California, United Sates of America
- Christopher E. Henze
-
Contributed equally to this work with: Michael H. Peters, Oscar Bastidas, Daniel S. Kokron, Christopher E. Henze
Roles Formal analysis, Methodology, Software, Writing – review & editing
Affiliation NASA Ames Research Center, Moffett Field, California, United Sates of America
Competing Interests
V.C.U (M.H.P.) entered an exclusive licensing agreement for "ACE2 Decoy Peptides in the Treatment of COVID-19" with Hoth Therapeutics, NY.